The Vanguard Group 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-01-31 09:54 am Sale |
2024-12-31 | 13G | Sana Biotechnology, Inc. SANA |
The Vanguard Group | 10,747,760 4.810% |
-2,435,792![]() (-18.48%) |
Filing |
2024-11-12 4:52 pm Unchanged |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
The Vanguard Group | 13,183,552 5.920% |
0 (Unchanged) |
Filing |
2024-11-04 2:10 pm Purchase |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
The Vanguard Group | 13,183,552 5.920% |
13,183,552![]() (New Position) |
Filing |